Seoul National University Bundang Hospital

Prof. Kim is an infectious disease physician as well as a medical director of antimicrobial stewardship program in the university-affiliated hospital. In addition, he is now a chief quality officer after being in charge of infection control office for about 13 years.

He has been actively involved in the advisory board for not only healthcare-associated infection but also antimicrobial resistance over a couple of decades in Korea. Now he participate in SHEA as a member of the external affairs committee since 2020 after being selected as an international ambassador in 2012. His research interests include molecular epidemiology and control of antibiotic-resistant pathogens, and also diagnosis and management of complicated S. aureus bacteremia.


American University of Beirut Medical Center

Souha Kanj is currently a tenured Professor of Medicine at the American University of Beirut Medical Center, Beirut, Lebanon, and Consulting Professor at the Duke University Medical Center, Durham, North Carolina, USA, where she also undertook her training in Internal Medicine and Infectious Diseases. Professor Kanj is extensively published, with more than 220 papers in national and international journals such as Mycoses, Infection, Lancet Infectious Diseases, and the Journal of the American Medical Association. She has also been an invited author of numerous book chapters, journal reviews, and UpToDate® cards and is currently Principal Investigator on research projects on topics related to antimicrobial resistance. Professor Kanj has contributed greatly to the work of the World Health Organization in various programs, such as the R&D Blueprint Annual Review of Priority Diseases, the Global Infection Prevention and Control Network, and the WHO Priority Pathogens List Project for Antimicrobial Resistant Bacteria. In 2020 she was appointed to serve on the WHO COVID-19 Guidance Development Group of experts. Professor Kanj is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the Royal College of Physicians, the European Society of Clinical Microbiology and Infectious Diseases, and the European Confederation of Medical Mycology. She is a member of the scientific affairs committee of ESCMID and was elected to the executive committee of the International Society of Antimicrobial Chemotherapy in November 2019. She has served on panels for international guidelines such as IDSA vertebral osteomyelitis and the recent ECMM global mucormycosis, and the rare yeasts guidelines. Professor Kanj received the Lebanese National Council for Scientific Research Award in 2014, the Abdul Hameed Shoman Award for researchers in the Arab world in 2017, and the Valkhof professorship in 2018 followed by an honorary degree in 2020 from Radboud University Medical Center in Nijmegen.


Centers for Disease Control and Prevention

John A. Jernigan, M.D., M.S. is currently Director of the Office of Prevention Research and Evaluation, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), and Adjunct Associate Professor of Medicine at the Emory University School of Medicine, Division of Infectious Diseases. In his work at CDC, Dr. Jernigan has played a leading helping design and implement research seeking innovative approaches to preventing healthcare associated infections and antibiotic resistance. He has authored/coauthored over 100 peer-reviewed publications on these topics. His role in CDC’s response to the COVID-19 pandemic has focused on the epidemiology and prevention of SARS-CoV-2 transmission in nursing home settings.


Geneva University Hospitals

Stephan Harbarth earned in 1993 his medical degree from Ludwig-Maximilians-University in Munich, Germany, and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston. He is board certified in infectious diseases and was appointed full professor at the University of Geneva in 2018. Dr Harbarth’s work has garnered several awards. His group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms and related clinical and health-economic burden.


University of Iowa

Dr. Diekema is a Professor of Internal Medicine and Pathology at the University of Iowa Carver College of Medicine. He is the associate director of the Clinical Microbiology Laboratory, and associate hospital epidemiologist at the University of Iowa Healthcare.

Dr. Diekema’s clinical and research interests include the role of the diagnostic laboratory in infection prevention and antimicrobial stewardship. He has served on national committees that establish standards in clinical microbiology and infection prevention, including the Clinical and Laboratory Standards Institute (CLSI) and the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), and he is a past-president of the Society for Healthcare Epidemiology of America (SHEA).


University of Zurich

Prof. Dr. phil. Lauren Clack is Assistant Professor of Implementation Science in Healthcare at the Medical Faculty, University of Zurich. She holds a PhD in Psychology from the University of Zurich and an MSc in Applied Ergonomics (Human Factors Engineering) from the University of Nottingham. From 2011 to 2020, she worked as a researcher and project leader, first at the University Hospitals of Geneva and then at the Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich. She specializes in the application of Implementation Science methodology and human-centered design to improve the systematic integration of evidence-based infection prevention and patient safety interventions into care.